(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are SALMONES CAMANCHAC, ADOCIA, and LAVIDE HOLDING.

Financial Asset	Price	Change	Updated (EST)
SALMONES CAMANCHAC (SACAM.OL)	23.00	26.37%	2024-07-01 12:42:48
ADOCIA (ADOC.PA)	8.50	8.97%	2024-07-01 12:45:10
LAVIDE HOLDING (LVIDE.AS)	0.27	7.94%	2024-07-01 12:02:49
FORFARMERS (FFARM.AS)	2.90	7.65%	2024-07-01 12:02:10
GENTIAN DIAGNOSTIC (GENT.OL)	58.00	7.41%	2024-07-01 12:40:10
ABIVAX (ABVX.PA)	12.54	7.36%	2024-07-01 12:44:53
AUTOSTORE HOLDINGS (AUTO.OL)	13.38	6.52%	2024-07-01 12:24:57
ARAMIS GROUP (ARAMI.PA)	4.44	6.47%	2024-07-01 12:45:53
NEKKAR (NKR.OL)	10.40	6.34%	2024-07-01 12:41:24
ASSYSTEM (ASY.PA)	56.30	6.24%	2024-07-01 12:46:05

The three biggest losers today are INTEROIL EXPL PROD, CELYAD ONCOLOGY, and BENFICA.

Financial Asset	Price	Change	Updated (EST)
INTEROIL EXPL PROD (IOX.OL)	7.10	-11.25%	2024-07-01 12:40:38
CELYAD ONCOLOGY (CYAD.BR)	0.25	-10.71%	2024-07-01 12:05:40
BENFICA (SLBEN.LS)	3.10	-6.06%	2024-07-01 12:23:04
POLIGHT (PLT.OL)	3.63	-5.23%	2024-07-01 12:42:26
FOUNTAIN (FOU.BR)	1.30	-4.41%	2024-07-01 12:06:24
STRONGPOINT (STRO.OL)	11.60	-4.12%	2024-07-01 12:43:55
FRONTLINE (FRO.OL)	268.30	-4.08%	2024-07-01 12:26:13
TEKNA HOLDING (TEKNA.OL)	5.76	-4%	2024-07-01 12:44:03
AB SCIENCE (AB.PA)	1.07	-3.94%	2024-07-01 12:44:45
VOW (VOW.OL)	6.63	-3.76%	2024-07-01 12:44:25

Winners today

1. SALMONES CAMANCHAC (SACAM.OL)

26.37% Price Change

Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic and Coho salmon products in various formats, such as whole, fillet, portion, and other products including bits and pieces, harasu, and scrape meat. It also exports its products. Salmones Camanchaca S.A. was incorporated in 2009 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. is a subsidiary of Camanchaca S.A.

Oslo Børs Benchmark Index_GI ended the session with SALMONES CAMANCHAC rising 26.37% to €23.00 on Monday while Oslo Børs Benchmark Index_GI jumped 0.42% to €1,428.29.

Earnings Per Share

As for profitability, SALMONES CAMANCHAC has a trailing twelve months EPS of kr-2.19.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.32%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 4000% and 168.8%, respectively.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 3.56 and the estimated forward annual dividend yield is 14.72%.

More news about SALMONES CAMANCHAC.

2. ADOCIA (ADOC.PA)

8.97% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA jumping 8.97% to €8.50 on Monday, following the last session’s downward trend. CAC 40 jumped 1.09% to €7,561.13, after four sequential sessions in a row of losses, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-1.9.

Moving Average

ADOCIA’s value is under its 50-day moving average of €9.07 and way higher than its 200-day moving average of €6.63.

Volatility

ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.88%, a negative 0.88%, and a positive 3.23%.

ADOCIA’s highest amplitude of average volatility was 8.65% (last week), 4.64% (last month), and 3.23% (last quarter).

More news about ADOCIA.

3. LAVIDE HOLDING (LVIDE.AS)

7.94% Price Change

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. is based in Amsterdam, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING rising 7.94% to €0.27 on Monday while AEX-Index fell 0.09% to €923.05.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.02.

Yearly Top and Bottom Value

LAVIDE HOLDING’s stock is valued at €0.27 at 22:40 EST, way below its 52-week high of €0.32 and way above its 52-week low of €0.18.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LAVIDE HOLDING’s stock is considered to be overbought (>=80).

Volatility

LAVIDE HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.98%, a negative 0.85%, and a positive 3.97%.

LAVIDE HOLDING’s highest amplitude of average volatility was 5.25% (last week), 4.11% (last month), and 3.97% (last quarter).

More news about LAVIDE HOLDING.

4. FORFARMERS (FFARM.AS)

7.65% Price Change

ForFarmers N.V. provides feed solutions for conventional and organic livestock farming in the Netherlands, Belgium, Germany, Poland, the United Kingdom, other European countries, and internationally. It offers compound feed and blends, feed for young animals and specialties, raw materials and coproducts, seeds, and fertilizers. The company is involved in production and delivery of feed, as well as engaged in logistics services. ForFarmers N.V. was founded in 1896 and is based in Lochem, the Netherlands.

AEX-Index ended the session with FORFARMERS jumping 7.65% to €2.90 on Monday, after three consecutive sessions in a row of losses. AEX-Index slid 0.09% to €923.05, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, FORFARMERS has a trailing twelve months EPS of €-0.01.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.57%.

More news about FORFARMERS.

5. GENTIAN DIAGNOSTIC (GENT.OL)

7.41% Price Change

Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research worldwide. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric immunoassay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a glomerular filtration rate marker for the diagnosis and therapeutic control of renal function; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and canine CRP immunoassay test kit, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine C-reactive protein in dog plasma and serum. It also provides SARS-CoV-2 total antibody immunoassay, quantitative antibody test captures the full immune response detecting antibodies targeting the S1-subunit. In addition, the company develops NT-proBNP Immunoassay, an aid in the diagnosis, monitoring and assessment of severity in individuals suspected of having congestive heart failure which is in product development phase. Further, it offers faecal calprotectin immunoassay, provides results of calprotectin in stool supporting diagnosis of inflammatory bowel disease; and faecal pancreatic elastase immunoassay which allows analysis of pancreatic elastase in stool to aid in diagnosis of pancreatic exocrine insufficiency. The company was founded in 2001 and is headquartered in Moss, Norway.

Oslo Børs Benchmark Index_GI ended the session with GENTIAN DIAGNOSTIC rising 7.41% to €58.00 on Monday while Oslo Børs Benchmark Index_GI jumped 0.42% to €1,428.29.

Earnings Per Share

As for profitability, GENTIAN DIAGNOSTIC has a trailing twelve months EPS of kr-0.38.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.82%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 22.5%, now sitting on 149.41M for the twelve trailing months.

Sales Growth

GENTIAN DIAGNOSTIC’s sales growth for the current quarter is 22.2%.

Moving Average

GENTIAN DIAGNOSTIC’s worth is way above its 50-day moving average of kr40.95 and way higher than its 200-day moving average of kr40.51.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GENTIAN DIAGNOSTIC’s stock is considered to be oversold (<=20).

More news about GENTIAN DIAGNOSTIC.

6. ABIVAX (ABVX.PA)

7.36% Price Change

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

CAC 40 ended the session with ABIVAX rising 7.36% to €12.54 on Monday, following the last session’s downward trend. CAC 40 rose 1.09% to €7,561.13, after four successive sessions in a row of losses, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, ABIVAX has a trailing twelve months EPS of €-3.43.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -211.42%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.9%, now sitting on 20k for the twelve trailing months.

More news about ABIVAX.

7. AUTOSTORE HOLDINGS (AUTO.OL)

6.52% Price Change

AutoStore Holdings Ltd., a robotic and software technology company, provides warehouse automation solutions in Norway, Germany, rest of Europe, the United States, Asia, and internationally. It offers grids, ports, bins, robots, workstations, controllers, and spare parts. The company also provides Qublt Fulfillment Platform, a warehouse management software; PickUpPort that offers frictionless in-store pickup options; ConveyorPort, a workstation that offers access to all bins; Carousel Port which is designed to maintain workstation productivity and coordination between the man and robot; SwingPort that provides work space outside of storage area; RelayPort that offers exchange between man and robot; and FusionPort and FusionPort Staging. It also offers warehouse robots, including R5, R5+, R5 Pro, R5+ Pro, and other products under the Red Line and Black names; Bin ResQ Robot; and Unify Analytics, a cloud-based service and data platform that automates the traditional way of collecting and analyzing real-time log data. In addition, the company offers installation, maintenance, and training of personnel services. It serves retail, grocery, third party logistic, industrial, and healthcare industries. The company was formerly known as AutoStore NewCo Ltd. and changed its name to AutoStore Holdings Ltd. in October 2021. AutoStore Holdings Ltd. was founded in 1996 and is headquartered in Nedre Vats, Norway.

Oslo Børs Benchmark Index_GI ended the session with AUTOSTORE HOLDINGS jumping 6.52% to €13.38 on Monday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.42% to €1,428.29, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, AUTOSTORE HOLDINGS has a trailing twelve months EPS of kr-0.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.2%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 21.6%, now sitting on 611.6M for the twelve trailing months.

More news about AUTOSTORE HOLDINGS.

8. ARAMIS GROUP (ARAMI.PA)

6.47% Price Change

Aramis Group SAS engages in the online sale of used vehicles in France, Belgium, the United Kingdom, Belgium, Austria, Italy, and Spain. It operates under the Aramisauto, Cardoen, Clicars, CarSupermarket, Onlinecars, and Brumbrum brands. The company was founded in 2001 and is based in Arcueil, France. Aramis Group SAS operates as a subsidiary of Stellantis Auto SAS.

CAC 40 ended the session with ARAMIS GROUP jumping 6.47% to €4.44 on Monday, after five successive sessions in a row of losses. CAC 40 jumped 1.09% to €7,561.13, after four consecutive sessions in a row of losses, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, ARAMIS GROUP has a trailing twelve months EPS of €-0.4.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ARAMIS GROUP’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for ARAMIS GROUP is 19836 which is 66.06% below its average volume of 58454.

More news about ARAMIS GROUP.

9. NEKKAR (NKR.OL)

6.34% Price Change

Nekkar ASA provides technologies, software, and automation solutions to offshore energy, renewables, and aquaculture industries. It operates through Syncrolift, Intellilift, and Techano Oceanlift segments. The company offers shipyard solutions, including shiplifting systems for launching and retrievals of vessels, and transfer systems for moving vessels around the yard; FastDocking products for efficient operations during docking and maintenance of vessels; and service and upgrades on shiplift and transfer systems, maintenance, spare replacements, and upgrades of small and larger components. In addition, the company offers load handling and lifting equipment, such as cranes, gangways, and fish transfer systems for the aquaculture and offshore energy industry; FiiZK closed cage solutions to avoid sea lice and enables waste collection from the harvest process; and SkyWalker, a wind turbine installation tool. Further, it develops industrial software solutions for digitalizing workflows through automation and remotely-controlled systems for drilling and offshore load handling. The company operates in Europe, Asia, Australia, New Zealand, North America, the United Arab Emirates, Africa, the United States, South America, India, Norway, and internationally. The company was formerly known as TTS Group ASA and changed its name to Nekkar ASA in July 2019. Nekkar ASA founded in 1966 and is headquartered in Kristiansand, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEKKAR rising 6.34% to €10.40 on Monday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.42% to €1,428.29, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, NEKKAR has a trailing twelve months EPS of kr0.76.

PE Ratio

NEKKAR has a trailing twelve months price to earnings ratio of 13.68. Meaning, the purchaser of the share is investing kr13.68 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.49%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 50.5%, now sitting on 626.09M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NEKKAR’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

NEKKAR’s stock is valued at kr10.40 at 22:40 EST, below its 52-week high of kr10.88 and way higher than its 52-week low of kr6.02.

More news about NEKKAR.

10. ASSYSTEM (ASY.PA)

6.24% Price Change

Assystem S.A. provides engineering and infrastructure project management services worldwide. It provides engineering services for the preparation, design, and construction of critical and complex infrastructure projects for public authorities and utility companies. The company also offers engineering, procurement, and construction management; project management consulting; field operation management; siting, licensing, and environmental; systems engineering and design; industrial control system; and compliance, risk monitoring, safety, and security services, as well as digital transformation consulting, integrating business information system, data as a source of value, and digital twin services for nuclear, hydrogen, renewable, grids, transportation, cities and territorial development, and defense and security infrastructure sectors. In addition, it provides decommissioning and waste management services, and operation and maintenance services. The company was formerly known as AssystemBrime S.A. and changed its name to Assystem S.A. in June 2005. The company was founded in 1966 and is based in Courbevoie, France. Assystem S.A. is a subsidiary of HDL Development.

CAC 40 ended the session with ASSYSTEM rising 6.24% to €56.30 on Monday, after three consecutive sessions in a row of losses. CAC 40 rose 1.09% to €7,561.13, after four consecutive sessions in a row of losses, on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, ASSYSTEM has a trailing twelve months EPS of €6.79.

PE Ratio

ASSYSTEM has a trailing twelve months price to earnings ratio of 8.29. Meaning, the purchaser of the share is investing €8.29 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ASSYSTEM’s stock is considered to be overbought (>=80).

Volatility

ASSYSTEM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.93%, a negative 0.42%, and a positive 1.42%.

ASSYSTEM’s highest amplitude of average volatility was 1.02% (last week), 1.52% (last month), and 1.42% (last quarter).

Volume

Today’s last reported volume for ASSYSTEM is 11088 which is 1.9% below its average volume of 11303.

More news about ASSYSTEM.

Losers Today

1. INTEROIL EXPL PROD (IOX.OL)

-11.25% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company in Argentina and Colombia. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD dropping 11.25% to €7.10 on Monday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.42% to €1,428.29, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr0.03.

PE Ratio

INTEROIL EXPL PROD has a trailing twelve months price to earnings ratio of 236.67. Meaning, the purchaser of the share is investing kr236.67 for every norwegian krone of annual earnings.

More news about INTEROIL EXPL PROD.

2. CELYAD ONCOLOGY (CYAD.BR)

-10.71% Price Change

Celyad Oncology SA, a biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. The company is developing shRNA non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the TCR without the need for gene editing; multi-specific CAR T-cell platform that focuses on the NKG2D receptor; NKG2D-based CAR T-cell therapies; and B7-H6 targeting CAT T-cell therapies. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery/PerkinElmer for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with CELYAD ONCOLOGY falling 10.71% to €0.25 on Monday while BEL 20 jumped 0.28% to €3,897.96.

Earnings Per Share

As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.36.

Volatility

CELYAD ONCOLOGY’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.83%, a negative 0.50%, and a positive 3.06%.

CELYAD ONCOLOGY’s highest amplitude of average volatility was 4.02% (last week), 2.60% (last month), and 3.06% (last quarter).

Volume

Today’s last reported volume for CELYAD ONCOLOGY is 48699 which is 212.91% above its average volume of 15563.

More news about CELYAD ONCOLOGY.

3. BENFICA (SLBEN.LS)

-6.06% Price Change

Sport Lisboa e Benfica – Futebol, SAD operates a sports club in Portugal. The company was founded in 1904 and is headquartered in Lisbon, Portugal. Sport Lisboa e Benfica – Futebol, SAD operates as a subsidiary of Sport Lisboa e Benfica SGPS SA.

PSI ended the session with BENFICA dropping 6.06% to €3.10 on Monday, following the last session’s upward trend. PSI rose 1.76% to €6,593.85, after four consecutive sessions in a row of losses, on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, BENFICA has a trailing twelve months EPS of €1.54.

PE Ratio

BENFICA has a trailing twelve months price to earnings ratio of 2.01. Meaning, the purchaser of the share is investing €2.01 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.79%.

Yearly Top and Bottom Value

BENFICA’s stock is valued at €3.10 at 22:40 EST, way below its 52-week high of €3.99 and way above its 52-week low of €2.62.

Volatility

BENFICA’s last week, last month’s, and last quarter’s current intraday variation average was 0.95%, 0.82%, and 2.54%.

BENFICA’s highest amplitude of average volatility was 4.16% (last week), 3.62% (last month), and 2.54% (last quarter).

Moving Average

BENFICA’s value is way above its 50-day moving average of €2.80 and above its 200-day moving average of €3.08.

Volume

Today’s last reported volume for BENFICA is 754 which is 66.09% below its average volume of 2224.

More news about BENFICA.

4. POLIGHT (PLT.OL)

-5.23% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; driver ASIC is designed to drive capacitive loads such as the TLens autofocus actuators; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. It serves smartphones and wearables, industrial, augmented reality, healthcare, and webcams markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT dropping 5.23% to €3.63 on Monday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.42% to €1,428.29, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.19.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.66%.

Volatility

POLIGHT’s last week, last month’s, and last quarter’s current intraday variation average was 0.31%, 1.81%, and 5.19%.

POLIGHT’s highest amplitude of average volatility was 3.66% (last week), 6.17% (last month), and 5.19% (last quarter).

Moving Average

POLIGHT’s value is way higher than its 50-day moving average of kr2.99 and way under its 200-day moving average of kr10.44.

More news about POLIGHT.

5. FOUNTAIN (FOU.BR)

-4.41% Price Change

Fountain S.A. engages in the sale, rental, and provision of machines for cold and hot drinks made from freeze-dried or grain products in in France, Belgium, the Netherlands, and rest of European Countries. It provides coffee and cartridge machines, and other beverages machines. The company offers its products through independent distributors. Fountain S.A. was incorporated in 1972 and is based in Braine l'Alleud, Belgium.

BEL 20 ended the session with FOUNTAIN falling 4.41% to €1.30 on Monday, after four successive sessions in a row of losses. BEL 20 rose 0.28% to €3,897.96, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, FOUNTAIN has a trailing twelve months EPS of €0.18.

PE Ratio

FOUNTAIN has a trailing twelve months price to earnings ratio of 7.22. Meaning, the purchaser of the share is investing €7.22 for every euro of annual earnings.

More news about FOUNTAIN.

6. STRONGPOINT (STRO.OL)

-4.12% Price Change

StrongPoint ASA develops, sells, and implements integrated technology solutions for in-store and online shopping in Scandinavia and internationally. The company offers various products and solutions comprising electronic shelf labels, scales and wrapping systems, and humanoid grocery robots; order and in-store picking, autonomous mobile robots, home delivery, grocery lockers, drive-thru, warehouse management system, and automated micro-fulfilment solutions; CashGuard, a cash management system; shop fitting services; and self-checkout solutions, as well as other retail technology comprising enterprise resource management system, point of sale software and terminals, fiscal printer, and other technologies. It also provides ShopFlow Logistics, a cloud based mobile logistics system for handling routines, such as receiving goods, inventory, balance adjustment, ordering labels printing, and waste management; and Vensafe, which automates in-store sales of restricted and theft-prone products. The company has a strategic partnership with Halodi Robotics to develop an in-store grocery retail robotics solution. It serves the grocery, pharmacy, do-it-yourself, fashion, and sports retail markets. The company was formerly known as PSI Group ASA and changed its name to StrongPoint ASA in September 2015. StrongPoint ASA was founded in 2000 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with STRONGPOINT falling 4.12% to €11.60 on Monday while Oslo Børs Benchmark Index_GI jumped 0.42% to €1,428.29.

Earnings Per Share

As for profitability, STRONGPOINT has a trailing twelve months EPS of kr-1.15.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.91%.

Yearly Top and Bottom Value

STRONGPOINT’s stock is valued at kr11.60 at 22:40 EST, way under its 52-week high of kr21.80 and way above its 52-week low of kr10.30.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 0.9 and the estimated forward annual dividend yield is 7.66%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 5.9%, now sitting on 1.32B for the twelve trailing months.

More news about STRONGPOINT.

7. FRONTLINE (FRO.OL)

-4.08% Price Change

Frontline plc, a shipping company, engages in the seaborne transportation of crude oil and oil products worldwide. It owns and operates oil and product tankers. As of December 31, 2023, the company operated a fleet of 76 vessels. It is also involved in the charter, purchase, and sale of vessels. The company was founded in 1985 and is based in Limassol, Cyprus.

Oslo Børs Benchmark Index_GI ended the session with FRONTLINE sliding 4.08% to €268.30 on Monday while Oslo Børs Benchmark Index_GI jumped 0.42% to €1,428.29.

Earnings Per Share

As for profitability, FRONTLINE has a trailing twelve months EPS of kr30.57.

PE Ratio

FRONTLINE has a trailing twelve months price to earnings ratio of 8.78. Meaning, the purchaser of the share is investing kr8.78 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.1%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 15, 2023, the estimated forward annual dividend rate is 20.26 and the estimated forward annual dividend yield is 10.59%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

FRONTLINE’s EBITDA is 192.84.

More news about FRONTLINE.

8. TEKNA HOLDING (TEKNA.OL)

-4% Price Change

Tekna Holding ASA engages in the development, manufacture, and sale of micron and nano powders, and plasma process solutions in North America, Europe, Asia, and internationally. The company offers spherical powders, such as titanium, nickel, and aluminum alloys, as well as tungsten and tantalum; and nanopowders, including nickel, silicon, and copper nanopowders, as well as boron nitride nanotubes for use in additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. It serves aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics industries. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.

Oslo Børs Benchmark Index_GI ended the session with TEKNA HOLDING sliding 4% to €5.76 on Monday while Oslo Børs Benchmark Index_GI rose 0.42% to €1,428.29.

Earnings Per Share

As for profitability, TEKNA HOLDING has a trailing twelve months EPS of kr-1.01.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.02%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TEKNA HOLDING’s stock is considered to be oversold (<=20).

Moving Average

TEKNA HOLDING’s worth is under its 50-day moving average of kr6.03 and way below its 200-day moving average of kr7.37.

Volume

Today’s last reported volume for TEKNA HOLDING is 50481 which is 16.89% below its average volume of 60742.

More news about TEKNA HOLDING.

9. AB SCIENCE (AB.PA)

-3.94% Price Change

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

CAC 40 ended the session with AB SCIENCE falling 3.94% to €1.07 on Monday, after three successive sessions in a row of losses. CAC 40 jumped 1.09% to €7,561.13, after four sequential sessions in a row of losses, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, AB SCIENCE has a trailing twelve months EPS of €-0.2.

Revenue Growth

Year-on-year quarterly revenue growth declined by 28.8%, now sitting on 777k for the twelve trailing months.

More news about AB SCIENCE.

10. VOW (VOW.OL)

-3.76% Price Change

Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. The company operates through Industrial Solutions, Maritime Solutions, and Aftersales segments. The Industrial Solutions segment offers and designs plants for processing biomass, food products, and industry residues. The Maritime Solution segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables chemicals; and tailor-made service and maintenance programs. In addition, it offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. Further, the company develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. It serves cruise, aquaculture, and landbased industries, as well as utilities. The company has a strategic partnership agreement with Repsol, S.A. for addressing the pressing issue of plastic waste; SAS IMPROVE for research and development of technological solutions; and Circon Energy, for equipment supply carbon refinery projects. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with VOW sliding 3.76% to €6.63 on Monday, after four sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.42% to €1,428.29, after two consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, VOW has a trailing twelve months EPS of kr-1.34.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.86%.

Yearly Top and Bottom Value

VOW’s stock is valued at kr6.63 at 22:40 EST, way below its 52-week high of kr17.80 and way above its 52-week low of kr4.80.

Sales Growth

VOW’s sales growth is 108.9% for the current quarter and 82.6% for the next.

More news about VOW.

Stay up to date with our winners and losers daily report